What does Dr. Thomas De Bo, orthopedist do?

Dr. Thomas De Bo, orthopedist is a specialist medical practice in Aalter. Private Limited, started on 17 May 2019, 1 establishment.

What is the address of Dr. Thomas De Bo, orthopedist?

The registered office of Dr. Thomas De Bo, orthopedist is located at Aalterveld 60, 9880 Aalter.

Is Dr. Thomas De Bo, orthopedist still active?

Yes. According to the CBE (27 September 2026) Dr. Thomas De Bo, orthopedist is active, legal situation “Normale toestand”, started on 17 May 2019.

Is Dr. Thomas De Bo, orthopedist registered on Peppol?

Yes, Dr. Thomas De Bo, orthopedist is registered on the Peppol network with ID 0208:0726847328.

What is the enterprise number of Dr. Thomas De Bo, orthopedist?

The enterprise number of Dr. Thomas De Bo, orthopedist is BE0726847328.

When was Dr. Thomas De Bo, orthopedist founded?

Dr. Thomas De Bo, orthopedist was founded on 17 May 2019.

Who are the directors of Dr. Thomas De Bo, orthopedist?

According to the 2025 annual accounts, the directors of Dr. Thomas De Bo, orthopedist are: Thomas De Bo.

Is Dr. Thomas De Bo, orthopedist a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 May 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Thomas De Bo, orthopedist make in 2025?

Dr. Thomas De Bo, orthopedist posted a profit after taxes of € 213,844 in financial year 2025.

What is the revenue of Dr. Thomas De Bo, orthopedist?

As a small company, Dr. Thomas De Bo, orthopedist is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 342,801.

Dr. Thomas De Bo, orthopedist (Private Limited) - Aalter

Dossier Dr. Thomas De Bo, orthopedist, printed on 27 September 2026 from databakkes.be/en/0726847328/dr-thomas-de-bo-orthopedist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Thomas De Bo, orthopedist from Aalter, company number BE0726847328, closed financial year 2025 with a result of € 213,844 after tax. For that financial year Dr. Thomas De Bo, orthopedist recorded a gross margin of € 342,801 and equity of € 164,764. Compared with financial year 2024, the result moved from € 205,599 to € 213,844. Profitable, and profit is growing. The buffer shrank hard: equity is 55 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 164,764

▼ 55% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 213,844

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 205,407

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 417,778 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 39,323

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,474

▲ 104% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,053

▼ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 279,035 Gross margin 2022: € 279,035 First fiscal year in the series	€ 274,175 Gross margin 2023: € 274,175 ▼ 2% vs 2022 (€ 279,035) Unfavourable step	€ 330,149 Gross margin 2024: € 330,149 ▲ 20% vs 2023 (€ 274,175) Favourable step	€ 342,801 Gross margin 2025: € 342,801 ▲ 4% vs 2024 (€ 330,149) Favourable step	▲ 4%
Profit after taxes	€ 170,038 Profit after taxes 2022: € 170,038 First fiscal year in the series	€ 160,217 Profit after taxes 2023: € 160,217 ▼ 6% vs 2022 (€ 170,038) Unfavourable step	€ 205,599 Profit after taxes 2024: € 205,599 ▲ 28% vs 2023 (€ 160,217) Favourable step	€ 213,844 Profit after taxes 2025: € 213,844 ▲ 4% vs 2024 (€ 205,599) Favourable step	▲ 4%
Equity	€ 343,804 Equity 2022: € 343,804 First fiscal year in the series	€ 343,804 Equity 2023: € 343,804 Unchanged (€ 343,804) Unchanged	€ 368,697 Equity 2024: € 368,697 ▲ 7% vs 2023 (€ 343,804) Favourable step	€ 164,764 Equity 2025: € 164,764 ▼ 55% vs 2024 (€ 368,697) Unfavourable step	▼ 55%
Total debts	€ 470,557 Total debts 2022: € 470,557 First fiscal year in the series	€ 364,962 Total debts 2023: € 364,962 ▼ 22% vs 2022 (€ 470,557) Favourable step	€ 288,676 Total debts 2024: € 288,676 ▼ 21% vs 2023 (€ 364,962) Favourable step	€ 409,090 Total debts 2025: € 409,090 ▲ 42% vs 2024 (€ 288,676) Unfavourable step	▲ 42%
Cash	€ 413,514 Cash 2022: € 413,514 First fiscal year in the series	€ 231,483 Cash 2023: € 231,483 ▼ 44% vs 2022 (€ 413,514) Unfavourable step	€ 137,971 Cash 2024: € 137,971 ▼ 40% vs 2023 (€ 231,483) Unfavourable step	€ 205,407 Cash 2025: € 205,407 ▲ 49% vs 2024 (€ 137,971) Favourable step	▲ 49%
Retained profit	€ 338,804 Retained profit 2022: € 338,804 First fiscal year in the series	€ 338,804 Retained profit 2023: € 338,804 Unchanged (€ 338,804) Unchanged	€ 363,697 Retained profit 2024: € 363,697 ▲ 7% vs 2023 (€ 338,804) Favourable step	€ 159,764 Retained profit 2025: € 159,764 ▼ 56% vs 2024 (€ 363,697) Unfavourable step	▼ 56%
Dividend	€ 343,313 Dividend 2022: € 343,313 First fiscal year in the series	€ 160,217 Dividend 2023: € 160,217 ▼ 53% vs 2022 (€ 343,313) Unchanged	€ 180,707 Dividend 2024: € 180,707 ▲ 13% vs 2023 (€ 160,217) Unchanged	€ 417,778 Dividend 2025: € 417,778 ▲ 131% vs 2024 (€ 180,707) Unchanged	▲ 131%
Bank debt	€ 180,000 Bank debt 2022: € 180,000 First fiscal year in the series	€ 99,640 Bank debt 2023: € 99,640 ▼ 45% vs 2022 (€ 180,000) Favourable step	€ 20,000 Bank debt 2024: € 20,000 ▼ 80% vs 2023 (€ 99,640) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 20,000) Favourable step	▼ 100%
Balance sheet total	€ 814,362 Balance sheet total 2022: € 814,362 First fiscal year in the series	€ 708,767 Balance sheet total 2023: € 708,767 ▼ 13% vs 2022 (€ 814,362) Unchanged	€ 657,372 Balance sheet total 2024: € 657,372 ▼ 7% vs 2023 (€ 708,767) Unchanged	€ 573,853 Balance sheet total 2025: € 573,853 ▼ 13% vs 2024 (€ 657,372) Unchanged	▼ 13%

Key figures of Dr. Thomas De Bo, orthopedist, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Thomas De Bo, orthopedist?

What happened at Dr. Thomas De Bo, orthopedist in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 213,844 (▲ 4% vs 2024). Source: NBB ↗
May 17, 2019 New establishment in Aalter. KBO
May 17, 2019 Start of the company according to the CBE. KBO

In short

From € 170,038 profit in 2022 to € 213,844 profit in 2025.

Paid € 237,251 in corporate taxes since 2022.

Best year ever: 2025, with € 213,844 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Thomas De Bo, orthopedist? We notify you, reason included.

Follow Dr. Thomas De Bo, orthopedist

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Thomas De Bo

Dr. Thomas De Bo, orthopedist

Behind Dr. Thomas De Bo, orthopedist is Thomas De Bo.

See the full network in the app

Directors

According to the 2025 annual accounts

Thomas De Bo

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Aalterveld 60

9880 Aalter

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0726.847.328
VAT number: BE 0726.847.328
Registered office: Aalterveld 60, 9880 Aalter
Names & denominations: Dr. Thomas De Bo, orthopedist
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 May 2019
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗